A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

NCT ID: NCT03819153

Last Updated: 2025-03-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

3533 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-17

Study Completion Date

2024-01-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in people with type 2 diabetes. Participants will get semaglutide (active medicine) or placebo ('dummy medicine'). This is known as participants' study medicine - which treatment participants get is decided by chance. Semaglutide is a medicine, doctors can prescribe in some countries for the treatment of type 2 diabetes. Participants will get the study medicine in a pen. Participants will use the pen to inject the medicine in a skin fold once a week. The study will close when there is enough information collected to show clear result of the study. The total time participants will be in this study is about 3 to 5 years, but it could be longer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
Sponsor staff involved in the clinical trial is masked according to company standard procedures

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Semaglutide

Participants are to receive semglutide for up to 5 years or more (event driven). The trial is event driven with a pre-defined minimum number of renal endpoint events for the primary endpoint.

Group Type EXPERIMENTAL

Semaglutide

Intervention Type DRUG

Participants are to inject semaglutide with a needle in the stomach, thigh or upper arm. Participants will use a pen to inject semaglutide under their skin. Participants will inject semaglutide 1 time a week on the same day of the week. Participants' dose of semaglutide will be changed over time. Participants start by taking a smaller amount (0.25 mg). After 4 weeks the dose will be increased to 0.5 mg. It will be increased more (to 1 mg) at 8 weeks. Participants will then stay on the same dose for the rest of the study.

Placebo

Participants are to receive placebo (semglutide) for up to 5 years or more (event driven). The trial is event driven with a pre-defined minimum number of renal endpoint events for the primary endpoint.

Group Type PLACEBO_COMPARATOR

Placebo (semaglutide)

Intervention Type DRUG

Participants are to inject placebo (semaglutide) with a needle in the stomach, thigh or upper arm. Participants will use a pen to inject placebo (semaglutide) under their skin. Participants will inject placebo (semaglutide) 1 time a week on the same day of the week. Participants' dose of placebo (semaglutide) will be changed over time. Participants start by taking a smaller amount (0.25 mg). After 4 weeks the dose will be increased to 0.5 mg. It will be increased more (to 1 mg) at 8 weeks. Participants will then stay on the same dose for the rest of the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Semaglutide

Participants are to inject semaglutide with a needle in the stomach, thigh or upper arm. Participants will use a pen to inject semaglutide under their skin. Participants will inject semaglutide 1 time a week on the same day of the week. Participants' dose of semaglutide will be changed over time. Participants start by taking a smaller amount (0.25 mg). After 4 weeks the dose will be increased to 0.5 mg. It will be increased more (to 1 mg) at 8 weeks. Participants will then stay on the same dose for the rest of the study.

Intervention Type DRUG

Placebo (semaglutide)

Participants are to inject placebo (semaglutide) with a needle in the stomach, thigh or upper arm. Participants will use a pen to inject placebo (semaglutide) under their skin. Participants will inject placebo (semaglutide) 1 time a week on the same day of the week. Participants' dose of placebo (semaglutide) will be changed over time. Participants start by taking a smaller amount (0.25 mg). After 4 weeks the dose will be increased to 0.5 mg. It will be increased more (to 1 mg) at 8 weeks. Participants will then stay on the same dose for the rest of the study.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female, age above or equal to 18 years at the time of signing informed consent. Japan: Male or female, age above or equal to 20 years at the time of signing informed consent
* Diagnosed with type 2 diabetes mellitus
* HbA1c less than or equal to 10% (less than or equal to 86 mmol/mol)
* Renal impairment defined either by:

1. serum creatinine-based eGFR greater than or equal to 50 and less than or equal to 75 mL/min/1.73 m\^2 (CKD-EPI) and UACR greater than 300 and less than 5000 mg/g or
2. serum creatinine-based eGFR greater than or equal to 25 and less than 50 mL/min/1.73 m\^2 (CKD-EPI) and UACR greater than 100 and less than 5000 mg/g

Exclusion Criteria

* Congenital or hereditary kidney diseases including polycystic kidney disease, autoimmune kidney diseases including glomerulonephritis or congenital urinary tract malformations
* Use of any glucagon-like peptide-1 (GLP-1) receptor agonist within 30 days prior to screening
* Myocardial infarction, stroke, hospitalisation for unstable angina pectoris or transient ischaemic attack within 60 days prior to the day of screening
* Presently classified as being in New York Heart Association (NYHA) Class IV heart failure
* Planned coronary, carotid or peripheral artery revascularisation
* Current (or within 90 days) chronic or intermittent haemodialysis or peritoneal dialysis
* Uncontrolled and potentially unstable diabetic retinopathy or maculopathy. Verified by a fundus examination performed within the past 90 days prior to screening or in the period between screening and randomisation. Pharmacological pupil-dilation is a requirement unless using a digital fundus photography camera specified for non-dilated examination
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Novo Nordisk A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Transparency (dept. 1452)

Role: STUDY_DIRECTOR

Novo Nordisk A/S

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dr. Terence Hart

Tuscumbia, Alabama, United States

Site Status

California Inst Of Renal Res

Chula Vista, California, United States

Site Status

John Muir Physician Network

Concord, California, United States

Site Status

John Muir Physicians Network

Concord, California, United States

Site Status

Valley Research

Fresno, California, United States

Site Status

California Institute of Renal Research

La Mesa, California, United States

Site Status

First Valley Med Grp Lancaster

Lancaster, California, United States

Site Status

Clinical Trials Research_Sacramento

Lincoln, California, United States

Site Status

VA Loma Linda Hlthcr Sys

Loma Linda, California, United States

Site Status

Long Beach Center For Clinical Research

Long Beach, California, United States

Site Status

VA Long Beach Healthcare System

Long Beach, California, United States

Site Status

Academic Medical Research Institute

Los Angeles, California, United States

Site Status

Valley Renal Medical Group Research

Northridge, California, United States

Site Status

Desert Oasis Hlthcr Med Group

Palm Springs, California, United States

Site Status

Saviers Medical Group

Port Hueneme, California, United States

Site Status

Inland Empire Clin Trials LLC

Rialto, California, United States

Site Status

Sierra Clinical Research

Roseville, California, United States

Site Status

California Research Foundation

San Diego, California, United States

Site Status

N America Res Inst - San Dimas

San Dimas, California, United States

Site Status

NorCal Endocrinology and Internal Medicine

San Ramon, California, United States

Site Status

Lundquist Inst-Biomed Innovtn

Torrance, California, United States

Site Status

San Fernando Valley Hlth Inst

West Hills, California, United States

Site Status

Rocky Mount Reg VA Med-DN

Aurora, Colorado, United States

Site Status

Creekside Endocrine Associates, PC

Denver, Colorado, United States

Site Status

BayCare Medical Group - Endocrinology

Clearwater, Florida, United States

Site Status

Horizon Rs Grp, Coral Gbls

Coral Gables, Florida, United States

Site Status

Cesar Figueroa M.D. P.A.

Delray Beach, Florida, United States

Site Status

Northeast Research Institute

Fleming Island, Florida, United States

Site Status

Palmetto Medical General Plaza

Hialeah, Florida, United States

Site Status

Encore Medical Research LLC

Hollywood, Florida, United States

Site Status

Homestead Associates In Research

Homestead, Florida, United States

Site Status

Life Spring Research

Miami, Florida, United States

Site Status

Oceane 7 Medical & Research Center, Inc.

Miami, Florida, United States

Site Status

International Physicians Research

Miami, Florida, United States

Site Status

San Marcus Res Clin Miami Lakes

Miami Lakes, Florida, United States

Site Status

Floridian Clinical Research, LLC

Miami Lakes, Florida, United States

Site Status

South Broward Research LLC

Miramar, Florida, United States

Site Status

Suncoast Clinical Research, Inc.

New Port Richey, Florida, United States

Site Status

Hanson Clinical Research Center

Port Charlotte, Florida, United States

Site Status

Northeast Research Institute

Saint Augustine, Florida, United States

Site Status

Cardiovascular Ctr of Sarasota

Sarasota, Florida, United States

Site Status

Clinical Research of Cent FL

Winter Haven, Florida, United States

Site Status

Ellipsis Group

Alpharetta, Georgia, United States

Site Status

Southeastern Clinical Research Institute, LLC

Augusta, Georgia, United States

Site Status

Endocrine Research Solutions

Roswell, Georgia, United States

Site Status

Solaris Clinical Research

Meridian, Idaho, United States

Site Status

Saltzer Medical Group Research

Nampa, Idaho, United States

Site Status

Apex Medical Research Inc

Chicago, Illinois, United States

Site Status

Clinical Invest Special_Gurnee

Gurnee, Illinois, United States

Site Status

North Suburban Nephrology LLC

Gurnee, Illinois, United States

Site Status

Endeavor Health

Skokie, Illinois, United States

Site Status

Velocity Clin. Res Valparaiso

Valparaiso, Indiana, United States

Site Status

West Broadway Clinic

Council Bluffs, Iowa, United States

Site Status

Four Rivers Clinical Research Inc

Paducah, Kentucky, United States

Site Status

Metropolitan Cardiovascular Consultants, LLC

Beltsville, Maryland, United States

Site Status

Brigham & Women's Hospital

Boston, Massachusetts, United States

Site Status

Northern Pines Hlth Ctr, PC

Buckley, Michigan, United States

Site Status

Aa Mrc Llc

Flint, Michigan, United States

Site Status

Elite Research Center

Flint, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Clinical Research Consultants, LLC

Kansas City, Missouri, United States

Site Status

Washington University_St. Louis_0

St Louis, Missouri, United States

Site Status

Univ of Nebraska Medical CTR

Omaha, Nebraska, United States

Site Status

Renal Medicine Associates

Albuquerque, New Mexico, United States

Site Status

Albany Medical College - Endo

Albany, New York, United States

Site Status

NYU Langone Neph Associates

Mineola, New York, United States

Site Status

NYU Nephrology Associates

New York, New York, United States

Site Status

Southgate Medical Group, LLP

West Seneca, New York, United States

Site Status

UNC Diabetes Care Center_Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Carteret Medical Group

Morehead City, North Carolina, United States

Site Status

Burke Primary Care

Morganton, North Carolina, United States

Site Status

Eastern Nephr Assoc, PLLC

New Bern, North Carolina, United States

Site Status

Whiteville Medical Associates

Whiteville, North Carolina, United States

Site Status

Accellacare

Wilmington, North Carolina, United States

Site Status

Brookview Hills Research Associates, LLC

Winston-Salem, North Carolina, United States

Site Status

Cincinnati Veterans Affairs Medical Center

Cincinnati, Ohio, United States

Site Status

Advanced Med Res Maumee

Maumee, Ohio, United States

Site Status

Alliance for Multispec Res

Norman, Oklahoma, United States

Site Status

Heritage Valley Medical Group Inc

Beaver, Pennsylvania, United States

Site Status

Lycoming Internal Medicine, Inc.

Jersey Shore, Pennsylvania, United States

Site Status

Northeast Endocrine Metabolic Associates

Philadelphia, Pennsylvania, United States

Site Status

Main Street Physician's Care

Little River, South Carolina, United States

Site Status

The Diabetes Center, LLC

Murrells Inlet, South Carolina, United States

Site Status

Family Medicine of SayeBrook LLC

Myrtle Beach, South Carolina, United States

Site Status

SC Nephrology and Hypertension

Orangeburg, South Carolina, United States

Site Status

AM Diabetes And Endocrinology Center

Bartlett, Tennessee, United States

Site Status

Univ Diab & Endo Consultants

Chattanooga, Tennessee, United States

Site Status

Vanderbilt Medical Center_Nashville

Nashville, Tennessee, United States

Site Status

Central Texas Clinical Research

Austin, Texas, United States

Site Status

Texas Diabetes & Endocrinology, P.A._Austin

Austin, Texas, United States

Site Status

Research Management, Inc

Austin, Texas, United States

Site Status

Osvaldo A. Brusco MD PA

Corpus Christi, Texas, United States

Site Status

Baylor Jack and Jane Hamilton

Dallas, Texas, United States

Site Status

Research Institute Of Dallas

Dallas, Texas, United States

Site Status

UT Southwestern Med Cntr

Dallas, Texas, United States

Site Status

MedResearch Inc

El Paso, Texas, United States

Site Status

Academy of Diabetes, T&E

El Paso, Texas, United States

Site Status

Juno Research, LLC_Houston

Houston, Texas, United States

Site Status

Juno Research, LLC_Houston

Houston, Texas, United States

Site Status

Southwest Clinical Trials

Houston, Texas, United States

Site Status

Southwest Houston Research Ltd

Houston, Texas, United States

Site Status

Carlos Arauz-Pacheco Md, Pa

Rockwall, Texas, United States

Site Status

Univ Of Texas Hlth Science Cntr

San Antonio, Texas, United States

Site Status

Sun Research Institute

San Antonio, Texas, United States

Site Status

Briggs Clinical Research, LLC

San Antonio, Texas, United States

Site Status

VIP Trials

San Antonio, Texas, United States

Site Status

NE Clin Res of San Antonio

San Antonio, Texas, United States

Site Status

Simcare Medical Research, LLC

Sugar Land, Texas, United States

Site Status

University of Utah School of Medicine

Salt Lake City, Utah, United States

Site Status

University of Vermont Medical Center

South Burlington, Vermont, United States

Site Status

York Clinical Research LLC

Norfolk, Virginia, United States

Site Status

McGuire VA Medical Center

Richmond, Virginia, United States

Site Status

VA Medical Center_Salem

Salem, Virginia, United States

Site Status

Amherst Family Practice P.C.

Winchester, Virginia, United States

Site Status

Capital Clin Res Ctr,LLC

Olympia, Washington, United States

Site Status

MultiCare Inst for Res & Innov

Spokane, Washington, United States

Site Status

Universal Research Group

Tacoma, Washington, United States

Site Status

Centro de Estudios Renales e Hipertensión Arterial

Villa Domínico, Buenos Aires, Argentina

Site Status

Centro Diabetológico y Nuticional Dr Alejandro Chertkoff

Buenos Aires, , Argentina

Site Status

Centro Medico Dra. Laura Maffei e Investigacion Clínica Apli

Buenos Aires, , Argentina

Site Status

FEPREVA

CABA, , Argentina

Site Status

Centro de Investigación Clínica

CABA, , Argentina

Site Status

Glenny Corp. S.A

CABA, , Argentina

Site Status

Medical Center of Diabetes and Nutrition

CABA, , Argentina

Site Status

Gosford Renal Research

Gosford, New South Wales, Australia

Site Status

Royal North Shore Hospital

St Leonards, New South Wales, Australia

Site Status

Westmead Hospital_Northmead

Westmead, New South Wales, Australia

Site Status

Core Research Centre

Milton, Queensland, Australia

Site Status

Monash Health Nephrology

Clayton, Victoria, Australia

Site Status

St Vincent's Hospital_Fitzroy_0

Fitzroy, Victoria, Australia

Site Status

Monash University Clinical Trial Centre

Melbourne, Victoria, Australia

Site Status

The Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Imeldaziekenhuis - Bonheiden - Department of Endocrinology

Bonheiden, , Belgium

Site Status

Universitair Ziekenhuis Brussel - Diabeteskliniek

Brussels, , Belgium

Site Status

UZ Brussel - Universitair Ziekenhuis Brussel

Brussels, , Belgium

Site Status

Cliniques Universitaires Saint-Luc - Serv Endocrinologie - Diabétologie

Brussels, , Belgium

Site Status

UZA - UZ Antwerpen - Department of Endocrinology

Edegem, , Belgium

Site Status

UZ Gent - Endocrinologie - Diabetologie

Ghent, , Belgium

Site Status

UZ Leuven - Endocrinology

Leuven, , Belgium

Site Status

Centre hospitalier universitaire de Liège (CHU de Liège)

Liège, , Belgium

Site Status

AZ Delta - Roeselare

Roeselare, , Belgium

Site Status

Instituto de Ensino e Pesquisa Clínica do Ceará Ltda

Fortaleza, Ceará, Brazil

Site Status

Instituto Pró-Renal Brasil

Curitiba, Paraná, Brazil

Site Status

Núcleo de Pesquisa Clínica do Rio Grande do Sul Ltda.

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital e Maternidade Dr. Christovão da Gama S.A.

Santo André, São Paulo, Brazil

Site Status

Instituto de Pesquisa Clinica (IPEC)

São Paulo, São Paulo, Brazil

Site Status

CPQuali Pesquisa Clínica Ltda

São Paulo, São Paulo, Brazil

Site Status

CPCLIN - Centro de Pesquisas Clínicas

São Paulo, São Paulo, Brazil

Site Status

Centro Médico Hospital da Bahia

Bahia, , Brazil

Site Status

Medical centre "Zdrave 1" OOD

Kozloduy, , Bulgaria

Site Status

UMHAT "Kaspela", Depart. Endocrinology and Metab. Diseases

Plovdiv, , Bulgaria

Site Status

MHAT "Dr. Ivan Seliminski"-Sliven

Sliven, , Bulgaria

Site Status

"Nader Yabrudi - ASMPVBE Individual practice"

Smolyan, , Bulgaria

Site Status

UMHAT Aleksandrovska

Sofia, , Bulgaria

Site Status

Medical Center Synexus Sofia

Sofia, , Bulgaria

Site Status

Medical Center "Nov Rehabilitatsionen center" EOOD

Stara Zagora, , Bulgaria

Site Status

LMC Clin Res Inc. Calgary

Calgary, Alberta, Canada

Site Status

University of Calgary

Calgary, Alberta, Canada

Site Status

The Bailey Clinic

Red Deer, Alberta, Canada

Site Status

BC Diabetes Canada

Vancouver, British Columbia, Canada

Site Status

Commonwealth Medical Clinic

Mount Pearl, Newfoundland and Labrador, Canada

Site Status

Eastern Health Authority

St. John's, Newfoundland and Labrador, Canada

Site Status

QE II Health - Pharmacy

Halifax, Nova Scotia, Canada

Site Status

Dr. Harpreet Bajaj

Brampton, Ontario, Canada

Site Status

Aggarwal and Assoc Ltd.

Brampton, Ontario, Canada

Site Status

JBN Medical Diagnostic Services Inc.

Burlington, Ontario, Canada

Site Status

LMC Clin Res Inc. Thornhill

Concord, Ontario, Canada

Site Status

LMC Endo Ctr (Etobicoke) Ltd

Etobicoke, Ontario, Canada

Site Status

Hamilton Med Res Group

Hamilton, Ontario, Canada

Site Status

Premier Clinical Trial Research Network (PCTRN)

Hamilton, Ontario, Canada

Site Status

Milestone Research

London, Ontario, Canada

Site Status

LMC Research Inc. Ottawa

Nepean, Ontario, Canada

Site Status

Lakeridge Health

Oshawa, Ontario, Canada

Site Status

Dr. James Cha

Oshawa, Ontario, Canada

Site Status

King Street Research

Oshawa, Ontario, Canada

Site Status

Bluewater Clin Res Group, Inc.

Sarnia, Ontario, Canada

Site Status

Bluewater Clin Res Group,Inc

Sarnia, Ontario, Canada

Site Status

Winterberry Family Medicine

Stoney Creek, Ontario, Canada

Site Status

LMC Endo Centres Ltd.(Bayview)

Toronto, Ontario, Canada

Site Status

UHN-Toronto General Hospital

Toronto, Ontario, Canada

Site Status

Mount Sinai Hospital

Toronto, Ontario, Canada

Site Status

Dr Anil K Gupta Med Prof Corp

Toronto, Ontario, Canada

Site Status

Dr. Anil K Gupta Med Prof Corp

Toronto, Ontario, Canada

Site Status

Ctr de rech Clin de Laval

Laval, Quebec, Canada

Site Status

Clinique de Recherche Medpharmgene Inc.

Montreal, Quebec, Canada

Site Status

Applied Med Inf Res

Montreal, Quebec, Canada

Site Status

Centre Medical Acadie

Montreal, Quebec, Canada

Site Status

Centre de Recherche Saint-Louis

Québec, , Canada

Site Status

Peking University People's Hospital-Endocrinology

Beijing, Beijing Municipality, China

Site Status

Peking University People's Hospital

Beijing, Beijing Municipality, China

Site Status

Beijing Pinggu Hospital-Endocrinology

Beijing, Beijing Municipality, China

Site Status

The Affiliated Hospital of Jiangsu University-Endocrinology

Zhenjiang, Jiangsu, China

Site Status

Jinan Central Hospital

Ji'nan, Shandong, China

Site Status

Centre Hospitalier Ardeche Nord

Annonay, , France

Site Status

Hospices Civils de Lyon-Hopital Cardiologique Louis Pradel-2

Bron, , France

Site Status

Centre Hospitalier Universitaire de Caen Normandie- Cote de Nacre-1

Caen, , France

Site Status

Centre Hospitalier Universitaire Grenoble Alpes-Site Nord Michallon-2

Grenoble - Cédex 09, , France

Site Status

Centre Hospitalier Departemental Vendee- La Roche Sur Yon

La Roche-sur-Yon, , France

Site Status

Les Hopitaux de Chartres-Hopital Louis Pasteur

Le Coudray, , France

Site Status

Groupe Sos Sante-Hopital Le Creusot-Hotel Dieu-1

Le Creusot, , France

Site Status

Groupe SOS Santé Hôtel Dieu

Le Creusot, , France

Site Status

Fondation Rothschild

Paris, , France

Site Status

Centre Hospitalier Universitaire Reims-Hopital Maison Blanche

Reims, , France

Site Status

Centre Hospitalier Universitaire de Nantes-Hopital Nord Laennec-1

Saint-Herblain, , France

Site Status

Hôpital Nord Laënnec- Service D'Endocrinologie

Saint-Herblain, , France

Site Status

Centre Hospitalier Universitaire de Toulouse-Hopital Rangueil-2

Toulouse, , France

Site Status

Centre de Recherche Clinique Portes Du Sud

Vénissieux, , France

Site Status

Diabetespraxis Mergentheim

Bad Mergentheim, , Germany

Site Status

Herz- und Diabeteszentrum NRW - Bad Oeynhausen

Bad Oeynhausen, , Germany

Site Status

DaVita Clinical Research Deutschland GmbH

Düsseldorf, , Germany

Site Status

Medizinische Klinik 4, Universitätsklinikum Erlangen

Erlangen, , Germany

Site Status

InnoDiab Forschung GmbH

Essen, , Germany

Site Status

Praxis Dr. med. M. Esser

Essen, , Germany

Site Status

Wendisch/Dahl Hamburg

Hamburg, , Germany

Site Status

Institut für Diabetesforschung GmbH Münster - Dr. med. Rose

Münster, , Germany

Site Status

Zentrum für klinische Studien Alexander Segner

Saint Ingbert-Oberwürzbach, , Germany

Site Status

University Hospital of Athens ATTIKON

Athens, Attica, Greece

Site Status

Iatriko Psychicou Private Clinic

Athens, , Greece

Site Status

General hospital of Athens 'G.Gennimatas'

Athens, , Greece

Site Status

Iatriko Athinon 'Palaiou Falirou'

Athens, , Greece

Site Status

General Hospital of Athens "Laiko", Nephrology Clinic

Athens, , Greece

Site Status

General Hospital of Lamia

Lamia, , Greece

Site Status

General University Hospital of Patras,Nephrology clinic

Rio, Patra, , Greece

Site Status

AHEPA General University Hospital

Thessaloniki, , Greece

Site Status

"Ippokrateio" G.H. of Thessaloniki

Thessaloniki, , Greece

Site Status

General Hospital of Thessaloniki "Ippokrateio"

Thessaloniki, , Greece

Site Status

EUROMEDICA Gen Clinic The/ki, Endocrin,Metabolism,Diabetes

Thessaloniki, , Greece

Site Status

"Thermi" Private Hosital

Thessaloniki, , Greece

Site Status

Genl Hosp of Thessaloniki, Papageorgiou ,Nephrology clinic

Thessaloniki, , Greece

Site Status

PTE-AOK II. Belgyogyaszati Klinika es Nephrologiai Centrum

Pécs, Baranya Vármegye, Hungary

Site Status

Lausmed Kft.

Baja, Bács-Kiskun county, Hungary

Site Status

Belinus Bt.

Debrecen, Hajdú-Bihar, Hungary

Site Status

Siófoki Kórház, Diabetológiai Szakrendelés

Siófok, Somogy County, Hungary

Site Status

Borbánya Praxis E.Ü. Kft.

Nyíregyháza, Szabolcs-Szatmar Varmegye, Hungary

Site Status

Péterfy Sándor utcai Kórház

Budapest, , Hungary

Site Status

MED-TIMA Kft.

Budapest, , Hungary

Site Status

Belinus Bt.

Debrecen, , Hungary

Site Status

Debreceni Egyetem Klinikai Központ Belgyógyászati Klinika D épület

Debrecen, , Hungary

Site Status

Debreceni Egyetem Klinikai Központ Belgyógyászati Klinika

Debrecen, , Hungary

Site Status

Békés Megyei Központi Kórház

Gyula, , Hungary

Site Status

Siófoki Kórház, Diabetológiai Szakrendelés

Siófok, , Hungary

Site Status

Markusovszky Egyetemi Oktatókórház

Szombathely, , Hungary

Site Status

Markusovszky Egyetemi Oktatókórház

Szombathely, , Hungary

Site Status

Endolife Specialty Hospitals

Guntur, Andhra Pradesh, India

Site Status

Ramaiah Memorial Hospital

Bangalore, Karnataka, India

Site Status

BGS Global Hospitals

Bangalore, Karnataka, India

Site Status

Lifecare Hospital and Research Centre

Bangalore, Karnataka, India

Site Status

Amrita Institute Of Medical Sciences & Research Centre

Kochi, Kerala, India

Site Status

Calicut Medical College

Kozhikode, Kerala, India

Site Status

Seth GS medical college and KEM Hospital

Mumbai, Maharashtra, India

Site Status

Poona hospital and research centre

Pune, Maharashtra, India

Site Status

Max Super Speciality Hospital, Saket

New Delhi, National Capital Territory of Delhi, India

Site Status

The Madras Medical Mission

Chennai, Tamil Nadu, India

Site Status

Osmania General Hospital

Hyderabad, Telangana, India

Site Status

MV Hospital and Research Centre

Lucknow, Uttar Pradesh, India

Site Status

Ajanta ResearchCentre

Lucknow, Uttar Pradesh, India

Site Status

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Lucknow, Uttar Pradesh, India

Site Status

Sanjay Gandhi Postgraduate Institute of Medical Science

Lucknow, Uttar Pradesh, India

Site Status

Apollo Multispeciality Hospital, Kolkata

Kolkata, West Bengal, India

Site Status

Sir Ganga Ram Hospital

New Delhi, , India

Site Status

Diabetes Clinic Wolfson MC

Holon, , Israel

Site Status

Diabetes Unit Hadassah Ein Karem MC

Jerusalem, , Israel

Site Status

Meir Medical Center

Kfar Saba, , Israel

Site Status

Kaplan Medical Center_Rehovot

Rehovot, , Israel

Site Status

Istituto Scientifico San Raffaele

Milan, MI, Italy

Site Status

AOUPol.Giaccone UOC Malattie Endocrine,Ricambio e Nutrizione

Palermo, PA, Italy

Site Status

Presidio Ospedaliero Cisanello

Pisa, PI, Italy

Site Status

AO Papa Giovanni XXIII UOC malattie Endocrine 1-Diabetologia

Bergamo, , Italy

Site Status

Azienda Ospedaliera Papa Giovanni XXIII

Bergamo, , Italy

Site Status

Ospedale Maggiore Policlinico UO Endocrinologia Diabetolgia

Milan, , Italy

Site Status

Azienda Ospedaliera Luigi Sacco

Milan, , Italy

Site Status

Azienda Ospealiero Universitaria Policlinico Umberto I

Roma, , Italy

Site Status

Azienda Ospedaliero - Universitaria Sant'Andrea

Roma, , Italy

Site Status

Seino Internal Medicine Clinic

Koriyama-shi, Fukushima, Japan, Japan

Site Status

Manda Memorial Hospital

Sapporo-shi, Hokkaido, Hokkaido, Japan, Japan

Site Status

Jinnouchi Hospital

Kumamoto, Kumamoto, Japan, Japan

Site Status

Heiwadai Hospital

Miyazaki, Miyazaki, Japan

Site Status

New Tokyo Heart Clinic

Chiba, , Japan

Site Status

Fukui Prefectural Hospital_Fukui

Fukui, , Japan

Site Status

Fukuoka Tokushukai Hospital

Fukuoka, , Japan

Site Status

Kawada Clinic

Gunma, , Japan

Site Status

Sasaki Hospital Internal Medicine

Hokkaido, , Japan

Site Status

Sasaki Internal Medicine

Hokkaido, , Japan

Site Status

Naka Kinen Clinic

Ibaraki, , Japan

Site Status

Nishiyamado Keiwa Hospital

Ibaraki, , Japan

Site Status

Kanazawa Medical University Hospital

Ishikawa, , Japan

Site Status

Yokohama Minoru Clinic

Kanagawa, , Japan

Site Status

H.E.C Science Clinic

Kanagawa, , Japan

Site Status

Shonan Takai Clinic

Kanagawa, , Japan

Site Status

Uji Tokushukai Medical Center

Kyoto, , Japan

Site Status

Kawasaki Medical School Hospital

Okayama, , Japan

Site Status

Takatsuki Red Cross Hospital

Osaka, , Japan

Site Status

Shimizu Clinic Fusa

Saitama, , Japan

Site Status

Oyama East Clinic

Tochigi, , Japan

Site Status

Tokyo Center Clinic

Tokyo, , Japan

Site Status

Fukuwa Clinic

Tokyo, , Japan

Site Status

Juntendo University Hospital_Tokyo

Tokyo, , Japan

Site Status

The University of Tokyo Hospital

Tokyo, , Japan

Site Status

Kato Clinic of Internal Medicine

Tokyo, , Japan

Site Status

Sugawara Clinic

Tokyo, , Japan

Site Status

University Malaya Medical Centre

Kuala Lumpur, Kuala Lumpur, Malaysia

Site Status

Hospital Sultanah Bahiyah

Alor Star, , Malaysia

Site Status

Hospital Raja Permaisuri Bainun Ipoh

Ipoh, Perak, , Malaysia

Site Status

Sarawak General Hospital

Kuching, , Malaysia

Site Status

Hospital Pulau Pinang

Pulau Pinang, , Malaysia

Site Status

Hospital Serdang

Serdang, , Malaysia

Site Status

Centro de Atención al Diabetico

Actopan, Hidalgo, Mexico

Site Status

Inst. Jaliscience de Investigacion en Diabetes y Obesidad SC

Guadalajara, Jalisco, Mexico

Site Status

Instituto Nacional de Nutricion - Unidad de Inv de Enf Metab

Distrito Federal, México, D.F., Mexico

Site Status

Instituto Nacional de Ciencias Médicas y Nutrición_Mexico City

Mexico City, México, D.F., Mexico

Site Status

Centro para el Desarrollo de la Medicina y la Asistencia

Culiacán, Sinaloa, Mexico

Site Status

Centro de Estudios de Investigación Metabólicos y Cardio

Ciudad Madero, Tamaulipas, Mexico

Site Status

Noordwest Ziekenhuisgroep

Alkmaar, , Netherlands

Site Status

Ziekenhuis Groep Twente Almelo

Almelo, , Netherlands

Site Status

EB Flevo Research BV

Almere Stad, , Netherlands

Site Status

Meander Medisch Centrum

Amersfoort, , Netherlands

Site Status

OLVG West

Amsterdam, , Netherlands

Site Status

Amsterdam UMC Lokatie VUMC

Amsterdam, , Netherlands

Site Status

Rijnstate Ziekenhuis

Arnhem, , Netherlands

Site Status

Tergooi, locatie Hilversum

Hilversum, , Netherlands

Site Status

Universitair Medisch Centrum Utrecht

Utrecht, , Netherlands

Site Status

Osteo Medic s.c. Artur Racewicz Jerzy Supronik

Bialystok, , Poland

Site Status

NZOZ WITAMED Poradnia Diabetologiczna

Kielce, , Poland

Site Status

Wojewodzki Szpital Specjalistyczny w Olsztynie

Olsztyn, , Poland

Site Status

Centrum Medyczne "Diabetika"

Radom, , Poland

Site Status

Uniwersytecki Szpital Kliniczny Nr 2 PUM W Szczecinie

Szczecin, , Poland

Site Status

Synexus Polska Sp. z o.o. Oddzial w Warszawie

Warsaw, , Poland

Site Status

Miedzyleski Szpital Specjalistyczny, Oddzial Nefrologiczny

Warsaw, , Poland

Site Status

Prywatny Gabinet Janusz Gumprecht

Zabrze, , Poland

Site Status

Reg. State Budget Healthc. Inst. Regional Clinical Hospital

Barnaul, , Russia

Site Status

City Hospital #5

Barnaul, , Russia

Site Status

Road Clinical Hospital at station Chelyabinsk

Chelyabinsk, , Russia

Site Status

PIH "Clin Hosp "RZD-Medicina" former Kazan OJSC Rus Railways

Kazan', , Russia

Site Status

SAHI Kuzbass Hospital(former Regional clinical hospital)

Kemerovo, , Russia

Site Status

National Medical Research Center of Endocrinology

Moscow, , Russia

Site Status

LLC RC Medical

Novosibirsk, , Russia

Site Status

Limited Law Company "Healthy Family" Medicine Center"

Novosibirsk, , Russia

Site Status

Penza Regional Clinical Hospital named after N.N. Burdenko

Penza, , Russia

Site Status

Joint Stock Company "Modern Medical Technologies"

Saint Petersburg, , Russia

Site Status

Aurora MedFort LLC

Saint Petersburg, , Russia

Site Status

Limited Liability Company "Energiya Zdoroviya"

Saint Petersburg, , Russia

Site Status

Medinet LLC

Saint Petersburg, , Russia

Site Status

LLC "Endocrinolog"

Samara, , Russia

Site Status

SHI Saratov City Clinical Hospital #9

Saratov, , Russia

Site Status

Regional clinical cardiology dispensary

Saratov, , Russia

Site Status

Regional Endocrinological Dispensary

Stavropol, , Russia

Site Status

Ulianovsk Regional Clinical Hospital

Ulyanovsk, , Russia

Site Status

Voronezh Regional Clinical Consultive-diagnostic Centre

Voronezh, , Russia

Site Status

Solovyev Clinical Emergency Hospital

Yaroslavl, , Russia

Site Status

Polyclinic #2 in Yoshkar-Ola

Yoshkar-Ola, , Russia

Site Status

MEDISPEKTRUM s.r.o.

Bratislava, , Slovakia

Site Status

FMC - dialyzacne sluzby, s.r.o.

Košice, , Slovakia

Site Status

IN-DIA s.r.o.

Lučenec, , Slovakia

Site Status

Narodny Endokrinologicky a diabetologicky ustav

Ľubochňa, , Slovakia

Site Status

DIABETIK s.r.o.

Nitra, , Slovakia

Site Status

Diabetologicka ambulancia MEDIKARD, s.r.o.

Prešov, , Slovakia

Site Status

ARETEUS s.r.o.

Trebišov, , Slovakia

Site Status

MUDr. Jana Rociakova s.r.o., ambulancia vnutorneho lekarstva

Žilina, , Slovakia

Site Status

FMC- dialyzacne sluzby, s.r.o.

Žilina, , Slovakia

Site Status

MEDIVASA, s.r.o., Diabetologicka ambulancia

Žilina, , Slovakia

Site Status

Diabetes Care Centre & CDE Centre

Benoni, Gauteng, South Africa

Site Status

LCS Clinical Research Unit

Cosmo City, Gauteng, South Africa

Site Status

Soweto Clinical Trial Centre

Johannesburg, Gauteng, South Africa

Site Status

Hemant Makan

Johannesburg, Gauteng, South Africa

Site Status

Wits Bara Clinical Trial Site

Johannesburg, Gauteng, South Africa

Site Status

Dr A Amod

Durban, KwaZulu-Natal, South Africa

Site Status

Precise Clinical Solutions (Pty) Ltd

Durban, KwaZulu-Natal, South Africa

Site Status

Tiervlei Trial Centre

Cape Town, Western Cape, South Africa

Site Status

Prof Rayner_Division of Nephrology

Cape Town, Western Cape, South Africa

Site Status

Hospital del Mar

Barcelona, , Spain

Site Status

Hospital Vall d'Hebron

Barcelona, , Spain

Site Status

Hospital Público da Mariña

Burela de Cabo, , Spain

Site Status

Hospital Universitario de Getafe

Getafe, , Spain

Site Status

Hospital Ribera Polusa

Lugo, , Spain

Site Status

Hospital Clínico Universitario de Valencia

Valencia, , Spain

Site Status

Hospital Universitario Doctor Peset

Valencia, , Spain

Site Status

Siriraj Hospital_Bangkoknoi, Bangkok

Bangkoknoi, Bangkok, Bangkok, Thailand

Site Status

Maharaj Nakorn Chiang Mai Hospital

Chiang Mai, Mueang Chiang Mai District, Thailand

Site Status

Phramongkutklao Hospital-nephrology

Bangkok, Rajathewee, Thailand

Site Status

King Chulalongkorn Memorial Hospital-Division of Nephrology

Bangkok, , Thailand

Site Status

King Chulalongkorn Memorial Hospital_Bangkok

Bangkok, , Thailand

Site Status

Phramongkutklao Hospital-nephrology

Bangkok, , Thailand

Site Status

Siriraj Hospital-Nephro

Bangkok, , Thailand

Site Status

Ankara Universitesi Ibni Sina Hastanesi

Ankara, , Turkey (Türkiye)

Site Status

Hacettepe Universitesi Tip Fakultesi Nefroloji Bilim Dali

Ankara, , Turkey (Türkiye)

Site Status

Gazi University Medical Faculty- Nephrology

Ankara, , Turkey (Türkiye)

Site Status

Akdeniz Universitesi Hastanesi Nefroloji Bilim Dali

Antalya, , Turkey (Türkiye)

Site Status

Aydin Adnan Menderes University Nephrology

Aydin, , Turkey (Türkiye)

Site Status

Istanbul University Cerrahpasa Medical Faculty

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Universitesi Istanbul Tip Fakultesi- Nefroloji

Istanbul, , Turkey (Türkiye)

Site Status

Goztepe Egitim Arastirma Hastanesi Nefroloji

Istanbul, , Turkey (Türkiye)

Site Status

T.C. Saglik Bakanligi Pendik Egitim ve Arastirma Hastanesi

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Kahramanmaras Sutcu Imam University

Kahramanmaraş, , Turkey (Türkiye)

Site Status

Kocaeli University Nephrology Department

Kocaeli, , Turkey (Türkiye)

Site Status

SI "Institute of Medical and Social Problems of Disability"

Dnipro, , Ukraine

Site Status

Ivano-Frankivsk Regional Clinical Hospital

Ivano-Frankivsk, , Ukraine

Site Status

CNPI "Kharkiv City Clinical Hospital #27"

Kharkiv, , Ukraine

Site Status

SI "National Institute of Therapy n.a. L.T. Malaya of NAMSU"

Kharkiv, , Ukraine

Site Status

Institute of Endocrinology and Metabolism of AMSU

Kyiv, , Ukraine

Site Status

CI "1st City Clinical Hospital of Poltava City Council"

Poltava, , Ukraine

Site Status

CI "Zaporizhia city clinical hospital #10"

Zaporizhia, , Ukraine

Site Status

Aberdeen Royal Infirmary

Aberdeen, , United Kingdom

Site Status

Diabetes Centre, Heartlands Hospital, Birmingham

Birmingham, , United Kingdom

Site Status

Ely Bridge Surgery

Cardiff, , United Kingdom

Site Status

Ninewells Hospital

Dundee, , United Kingdom

Site Status

Western General Hospital

Edinburgh, , United Kingdom

Site Status

Glasgow Clinical Research Facility

Glasgow, , United Kingdom

Site Status

The Diabetes Centre

Ipswich, , United Kingdom

Site Status

North Middlesex Hospital

London, , United Kingdom

Site Status

Royal Free - Diabetes

London, , United Kingdom

Site Status

Lister Hospital

Stevenage, , United Kingdom

Site Status

St Georges Hospital

Tooting, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Australia Belgium Brazil Bulgaria Canada China France Germany Greece Hungary India Israel Italy Japan Malaysia Mexico Netherlands Poland Russia Slovakia South Africa Spain Thailand Turkey (Türkiye) Ukraine United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Rossing P, Baeres FMM, Bakris G, Bosch-Traberg H, Gislum M, Gough SCL, Idorn T, Lawson J, Mahaffey KW, Mann JFE, Mersebach H, Perkovic V, Tuttle K, Pratley R. The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant. 2023 Aug 31;38(9):2041-2051. doi: 10.1093/ndt/gfad009.

Reference Type BACKGROUND
PMID: 36651820 (View on PubMed)

Natale P, Green SC, Tunnicliffe DJ, Pellegrino G, Toyama T, Strippoli GF. Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes. Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.

Reference Type DERIVED
PMID: 39963952 (View on PubMed)

Mendonca L, Moura H, Chaves PC, Neves JS, Ferreira JP. The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials. Clin J Am Soc Nephrol. 2024 Oct 8;20(2):159-68. doi: 10.2215/CJN.0000000584. Online ahead of print.

Reference Type DERIVED
PMID: 39480988 (View on PubMed)

Kosiborod MN, Deanfield J, Pratley R, Borlaug BA, Butler J, Davies MJ, Emerson SS, Kahn SE, Kitzman DW, Lingvay I, Mahaffey KW, Petrie MC, Plutzky J, Rasmussen S, Ronnback C, Shah SJ, Verma S, Weeke PE, Lincoff AM; SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM Trial Committees and Investigators. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials. Lancet. 2024 Sep 7;404(10456):949-961. doi: 10.1016/S0140-6736(24)01643-X. Epub 2024 Aug 30.

Reference Type DERIVED
PMID: 39222642 (View on PubMed)

Pratley RE, Tuttle KR, Rossing P, Rasmussen S, Perkovic V, Nielsen OW, Mann JFE, MacIsaac RJ, Kosiborod MN, Kamenov Z, Idorn T, Hansen MB, Hadjadj S, Bakris G, Baeres FMM, Mahaffey KW; FLOW Trial Committees and Investigators. Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial. J Am Coll Cardiol. 2024 Oct 22;84(17):1615-1628. doi: 10.1016/j.jacc.2024.08.004. Epub 2024 Aug 30.

Reference Type DERIVED
PMID: 39217553 (View on PubMed)

Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, Charytan DM, Hadjadj S, Gillard P, Gorriz JL, Idorn T, Ji L, Mahaffey KW, Perkovic V, Rasmussen S, Schmieder RE, Pratley RE, Tuttle KR. Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nat Med. 2024 Oct;30(10):2849-2856. doi: 10.1038/s41591-024-03133-0. Epub 2024 Jun 24.

Reference Type DERIVED
PMID: 38914124 (View on PubMed)

De La Flor JC, Moral E, Deira J, Monzon T, Valga F, Albarracin C, Rodeles M. Response to "Experience with dulaglutide in an obese diabetic patient on incremental peritoneal dialysis". Response to related letter. Nefrologia (Engl Ed). 2024 May-Jun;44(3):444-446. doi: 10.1016/j.nefroe.2023.10.010. Epub 2024 Jun 10. No abstract available.

Reference Type DERIVED
PMID: 38862303 (View on PubMed)

Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, Baeres FMM, Idorn T, Bosch-Traberg H, Lausvig NL, Pratley R; FLOW Trial Committees and Investigators. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. 2024 Jul 11;391(2):109-121. doi: 10.1056/NEJMoa2403347. Epub 2024 May 24.

Reference Type DERIVED
PMID: 38785209 (View on PubMed)

Cohen S, Sternlicht H, Bakris GL. Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor Agonists. Curr Diab Rep. 2022 May;22(5):213-218. doi: 10.1007/s11892-022-01461-4. Epub 2022 Apr 20.

Reference Type DERIVED
PMID: 35441935 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

U1111-1217-6259

Identifier Type: OTHER

Identifier Source: secondary_id

2018-002878-50

Identifier Type: REGISTRY

Identifier Source: secondary_id

JapicCTI-194843

Identifier Type: REGISTRY

Identifier Source: secondary_id

NN9535-4321

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

DIALYSIS-TIR Study
NCT06042153 ACTIVE_NOT_RECRUITING PHASE4
Metformin as RenoProtector of Progressive Kidney Disease
NCT03831464 ACTIVE_NOT_RECRUITING PHASE3